QRX-1204

N/A

Report date: 2024/01/31 17:55:58
NME

Base Information

Drug NameQRX-1204
Drug Alias NameQRX-1204
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionRNA interferenceNeurogenic locus notch homolog protein 3 modulators
TargetsNeurogenic locus notch homolog protein 3
Therapy Area/IndicationsCADASIL
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProqr Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesProqr Therapeutics
Inactive CompaniesN/A
Active IndicationsCADASIL
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A